Journal of Pharmacogenomics & Pharmacoproteomics

Asha R Kallianpur

Asha R Kallianpur
Genomic Medicine Institute, Lerner Research Institute
USA

Biography

Dr. Asha R. Kallianpur is a physician scientist and epidemiologist on the faculty of the Department of Medicine and Institute for Medicine Public Health at Vanderbilt University. She is trained in Internal Medicine and Hematology.

Research Interest

Genetic disorders of iron metabolism such as hereditary hemochromatosis, oxidative injury, and the impact of variation in iron transport on chronic diseases and cancer. Her research team actively investigates the role of nuclear and mitochondrial genomic variation, including variation in iron transport, on breast and endometrial cancer etiology, cancer survival, and in chronic disease complications. With collaborators in Hematology, Infectious Diseases, Neurology, and Neuropathology. Dr. Kallianpur has studied the role of iron transport in chemotherapy toxicities and in antiretroviral drug-associated complications such as neuropathy and lipoatrophy, major problems for patients with cancer and HIV/AIDS, respectively, worldwide. The consistent theme of her translational work has been to develop the evidence base for interventions to improve clinical outcomes for patients with, or at risk for, cancer and other chronic conditions. Her ultimate goal is to translate accumulated knowledge about the relative risks and benefits of dietary and supplemental iron, into low-cost interventions for primary and secondary disease prevention.